Sign in

You're signed outSign in or to get full access.

Company not found (ASAI)

Recent press releases and 8-K filings for ASAI.

Assaí Reports Q3 2025 Results, Continues Deleveraging Amidst Challenging Market
ASAI
Earnings
Guidance Update
New Projects/Investments
  • Assaí maintained its deleveraging trajectory in Q3 2025, reducing net debt by BRL 500 million and gross debt by BRL 500 million, achieving its lowest debt-to-EBITDA ratio since 2021.
  • The company reported an EBITDA margin of 7.6% (up 0.2% post-IFRS) and a net income of BRL 195 million with a 1.1% net margin for the quarter, despite a challenging environment.
  • High interest rates and consumer debt led to a setback in volumes for retail formats servicing CDE classes (e.g., 8.3% for mini markets, grocery stores, and independent players) and B2B customers.
  • Assaí projects BRL 700 million in CapEx for next year, focusing on selective projects, and does not anticipate needing new cash for debt maturities in 2025 or 2026.
  • New strategic initiatives include expanding into medication, vitamins, supplements, HPC, developing private label products, and launching financial services with a pilot for B2B and B2C customers.
Nov 7, 2025, 2:00 PM
Fintool

Ask Fintool AI Agent

Get instant answers from SEC filings, earnings calls & more